Kura Oncology, Inc(KURA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KURA Kura Oncology, Inc

休市中 05-10 16:00:00 EDT

20.71

-0.06

-0.29%

盘后20.71

+0.000.00%

19:18 EDT

最高21.03	最低20.02	成交量57.35万
今开20.95	昨收20.77	日振幅4.86%
总市值15.78亿	流通市值10.32亿	总股本7,618万
成交额1,178万	换手率1.15%	流通股本4,985万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KURA","market":"US","secType":"STK","nameCN":"Kura Oncology, Inc","latestPrice":20.71,"timestamp":1715371200000,"preClose":20.77,"halted":0,"volume":573475,"hourTrading":{"tag":"盘后","latestPrice":20.71,"preClose":20.71,"latestTime":"19:18 EDT","volume":14153,"amount":293107.97,"timestamp":1715383114873},"delay":0,"floatShares":49849939,"shares":76180620,"eps":-2.179989,"marketStatus":"休市中","marketStatusCode":7,"change":-0.06,"latestTime":"05-10 16:00:00 EDT","open":20.95,"high":21.03,"low":20.02,"amount":11780271.837250002,"amplitude":0.048628,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.179989,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715587200000},"adr":0,"listingDate":1446699600000,"adjPreClose":20.77,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":20.71,"preClose":20.71,"latestTime":"19:18 EDT","volume":14153,"amount":293107.97,"timestamp":1715383114873},"volumeRatio":0.9528856831680238},"requestUrl":"/m/hq/s/KURA/tweets","defaultTab":"tweets","newsList":[{"id":"2434987676","title":"Kura Oncology, Inc.2024财年第一财季实现净利润-49.53百万美元，同比减少45.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434987676","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434987676?lang=zh_cn&edition=full","pubTime":"2024-05-12 00:19","pubTimestamp":1715444354,"startTime":"0","endTime":"0","summary":"3月31日，Kura Oncology, Inc.公布财报，公告显示公司2024财年第一财季净利润为-49.53百万美元，同比减少45.38%；其中营业收入为0.00美元，每股基本收益为-0.59美元。从资产负债表来看，Kura Oncology, Inc.总负债48.82百万美元，其中短期债务1.36百万美元，资产负债比为0.12，流动比率为0.17。机构评级：截至2024年3月31日，当前有12家机构对Kura Oncology, Inc.目标价做出预测，其中目标均价为30.25美元，其中最低目标价为21.00美元，最高目标价为37.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405120019188af92903&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405120019188af92903&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432966401","title":"库拉肿瘤公司（Kura Oncology Inc）公布截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2432966401","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432966401?lang=zh_cn&edition=full","pubTime":"2024-05-03 07:03","pubTimestamp":1714690995,"startTime":"0","endTime":"0","summary":"   * Kura Oncology Inc   报告了截至3月底的季度调整后每股亏损59美分，低于去年同期的每股-50美分。12位分析师对该季度的平均预期是每股亏损55美分。华尔街预期为每股-68美分至-44美分。* Kura Oncology Inc 报告的本季度每股收益为亏损 59 美分。* 该公司当季亏损 4953 万美元。* Kura Oncology Inc本季度股价下跌了4.9%，今年迄今为止上涨了41.0%。5月2日 - 预测变化   * 过去三个月，分析师的平均盈利预期下降了约 2%。华尔街对 Kura Oncology Inc 的 12 个月目标价中位数为 32.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432635498","title":"Kura Oncology, Inc.盘中异动 急速上涨5.05%报20.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432635498","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432635498?lang=zh_cn&edition=full","pubTime":"2024-05-02 03:01","pubTimestamp":1714590113,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日03时01分，Kura Oncology, Inc.股票出现异动，股价快速拉升5.05%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为2.39%。其相关个股中，Cytomx Therapeutics, Inc.、Bioatla, Inc.、Cyclacel Pharmaceuticals, Inc.涨幅较大，Palisade Bio, Inc.、Cyclacel Pharmaceuticals, Inc.、Cytomx Therapeutics, Inc.较为活跃，换手率分别为1415.30%、1222.24%、268.04%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为188.34%、99.53%、77.43%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050203015487e853be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050203015487e853be&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429115524","title":"Kura Oncology, Inc.盘中异动 大幅上涨5.03%报19.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429115524","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429115524?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:19","pubTimestamp":1713881996,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时19分，Kura Oncology, Inc.股票出现波动，股价急速上涨5.03%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.27%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。该信息摘要如下：HC Wainwright & Co.：重申Kura Oncology评级，由买入调整至买入评级, 目标价32.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232219567922b2e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232219567922b2e0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429977911","title":"HC Wainwright & Co.：重申Kura Oncology(KURA.US)评级，由买入调整至买入评级, 目标价32.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2429977911","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429977911?lang=zh_cn&edition=full","pubTime":"2024-04-23 01:55","pubTimestamp":1713808510,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Kura Oncology(KURA.US)评级，由买入调整至买入评级, 目标价32.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042301551187a24ca5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042301551187a24ca5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429597668","title":"Kura Oncology, Inc.盘中异动 股价大涨5.02%报18.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429597668","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429597668?lang=zh_cn&edition=full","pubTime":"2024-04-22 23:57","pubTimestamp":1713801420,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日23时57分，Kura Oncology, Inc.股票出现波动，股价大幅上涨5.02%。截至发稿，该股报18.41美元/股，成交量31.3732万股，换手率0.41%，振幅2.68%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.20%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222357007a549cb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222357007a549cb1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427759055","title":"Kura Oncology, Inc.盘中异动 股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427759055","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427759055?lang=zh_cn&edition=full","pubTime":"2024-04-13 02:41","pubTimestamp":1712947261,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日02时41分，Kura Oncology, Inc.股票出现波动，股价快速跳水5.14%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.56%。其相关个股中，Paxmedica, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为3675.78%、1450.50%、102.76%，振幅较大的相关个股有Paxmedica, Inc.、Allarity Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为93.97%、73.57%、58.59%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130241017920408b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130241017920408b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424202640","title":"Kura Oncology, Inc.盘中异动 急速下挫5.04%报20.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424202640","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424202640?lang=zh_cn&edition=full","pubTime":"2024-04-03 01:40","pubTimestamp":1712079650,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日01时40分，Kura Oncology, Inc.股票出现异动，股价大幅下挫5.04%。截至发稿，该股报20.72美元/股，成交量22.489万股，换手率0.30%，振幅2.15%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.77%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403014050791e8260&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403014050791e8260&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420477414","title":"Kura Oncology, Inc.盘中异动 早盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420477414","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420477414?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:52","pubTimestamp":1710769972,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时52分，Kura Oncology, Inc.股票出现波动，股价快速下跌5.06%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、Immuneering Corporation、Celularity Inc C/Wts 16/07/2026 涨幅较大，Zyversa Therapeutics, Inc.、Scisparc Ltd.、Tc Biopharm  Plc较为活跃，换手率分别为64.97%、14.39%、12.39%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Immuneering Corporation、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为38.07%、29.27%、28.71%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031821525287e79c5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031821525287e79c5a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414374963","title":"库拉肿瘤公司（Kura Oncology Inc）公布截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2414374963","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414374963?lang=zh_cn&edition=full","pubTime":"2024-02-28 07:45","pubTimestamp":1709077506,"startTime":"0","endTime":"0","summary":"   * Kura Oncology Inc   报告了截至12月底的季度调整后每股亏损55美分，低于去年同期的每股收益-49美分。华尔街预期为每股-68美分至-49美分。* Kura Oncology Inc 报告的本季度每股收益为亏损 55 美分。* 该公司当季亏损 4279 万美元。* 本季度，Kura Oncology Inc 的股价上涨了 44.2%。2月27日 - 预测变化   * 在过去三个月中，分析师的平均盈利预测上升了约 1%。华尔街对 Kura Oncology Inc 的 12 个月目标价中位数为 32.00 美元。本摘要由 LSEG 2 月 27 日 11:44 p.m. UTC 数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413238719","title":"Kura Oncology Inc   预计每股亏损 55 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2413238719","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413238719?lang=zh_cn&edition=full","pubTime":"2024-02-24 05:05","pubTimestamp":1708722339,"startTime":"0","endTime":"0","summary":"   * Kura Oncology Inc    将于2月27日公布截至2023年12月31日的财报，预计季度收入将保持不变。*    * LSEG的分析师平均预计Kura Oncology Inc每股亏损55美分。* 华尔街对 Kura Oncology Inc 的 12 个月目标价中位数为 32.00 美元，高于其最新收盘价 19.59 美元。2月23日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2412166707","title":"Kura Oncology Inc   预计每股亏损 55 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2412166707","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2412166707?lang=zh_cn&edition=full","pubTime":"2024-02-20 06:21","pubTimestamp":1708381298,"startTime":"0","endTime":"0","summary":"   * Kura Oncology Inc    将于2月21日公布截至2023年12月31日的财报，预计季度营收将没有变化()    *    * LSEG 的分析师平均预计 Kura Oncology Inc 每股亏损 55 美分。* 华尔街对 Kura Oncology Inc 的 12 个月目标价中位数为 32.00 美元，高于其上次收盘价 20.62 美元。2月19日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2407369286","title":"BUZZ-血癌治疗试验数据良好，库拉公司业绩大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2407369286","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2407369286?lang=zh_cn&edition=full","pubTime":"2024-01-30 23:50","pubTimestamp":1706629831,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    1月30日 - ** 库拉肿瘤  股价上涨14%，创下21.28美元的历史新高** 该公司称， (link)，在一项早期试验中，使用其药物ziftomenib治疗新确诊患者的癌症100%完全缓解。** 称正在评估该药物与治疗急性髓性白血病（一种血癌）的标准疗法相结合的效果 ** 截至上次收盘，该公司股价在过去12个月中上涨了41.2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2406942345","title":"BUZZ--美国股票走势-Netfilx、杜邦、贝克休斯","url":"https://stock-news.laohu8.com/highlight/detail?id=2406942345","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2406942345?lang=zh_cn&edition=full","pubTime":"2024-01-25 00:07","pubTimestamp":1706112422,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      1月24日 - 华尔街周三大涨，基准标普 500 指数盘中创下历史新高，原因是 Netflix 在用户增长超出预期后大涨，而芯片股则因 ASML 的强劲盈利而上涨。美东时间10:40，道琼斯工业平均指数  上涨0.18%，报37,974.44点。标普500指数  上涨0.62%，报4894.76点；纳斯达克综合指数  上涨1.08%，报15592.887点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2405444949","title":"BUZZ--美国股票走势-黄金矿工、TE Connectivity、安费诺","url":"https://stock-news.laohu8.com/highlight/detail?id=2405444949","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2405444949?lang=zh_cn&edition=full","pubTime":"2024-01-24 22:21","pubTimestamp":1706106109,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：          *      The Day Ahead newsletter:          *      The Morning News Call newsletter:      1月24日 - 美国股指期货周三显示，Netflix因用户增长超出预期而大涨，同时ASML的强劲盈利帮助推动芯片股上涨，华尔街破纪录的涨势有望延续。美东时间9:08，道指电子盘  上涨 0.35%，报 38,221 点。标普500指数小型股  上涨0.51%，报4919.75点；纳斯达克100指数小型股  上涨0.78%，报17667.5点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2405412437","title":"BUZZ-1.5 亿美元溢价 PIPE 融资，Kura Oncology 业绩大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2405412437","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2405412437?lang=zh_cn&edition=full","pubTime":"2024-01-24 20:46","pubTimestamp":1706100404,"startTime":"0","endTime":"0","summary":"    1月24日 - ** Kura Oncology  公司溢价融资后，股价盘前大涨42%至19.05美元，创18年来新高** 该公司称，同意在 PIPE 中出售 870 万股  股份，包括约 730 万份预先筹资的认股权证，总收益为 1.5 亿美元。** 收购价为 17.25 美元，比股票最后收盘价溢价 28.5** 融资包括现有机构投资者的参与，其中包括 EcoR1 Capital、Deerfield Management 的关联公司和 Suvretta Capital。** Kura表示，计划利用PIPE募集资金净额为研发和其他研究项目提供资金，加上现金和投资，预计可为当前运营提供资金至2027年。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kuraoncology.com","stockEarnings":[{"period":"1week","weight":0.0039},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.0371},{"period":"6month","weight":1.4308},{"period":"1year","weight":0.6702},{"period":"ytd","weight":0.4402}],"compareEarnings":[{"period":"1week","weight":0.0187},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0392},{"period":"6month","weight":0.1821},{"period":"1year","weight":0.2638},{"period":"ytd","weight":0.0958}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kura Oncology, Inc.是一家临床阶段的生物制药公司发现和开发个性化的治疗实体肿瘤和血癌的治疗。该公司专注于开发小分子产品的候选人，靶细胞信号转导途径，是重要的推动某些癌症的进展。该公司的目标是使用分子诊断，以确定癌症谁可能受益于该公司有针对性的产品候选人。 该公司成立于2007年11月特拉华州。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.037302},{"month":2,"riseRate":0.555556,"avgChangeRate":0.03336},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.017219},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.03462},{"month":5,"riseRate":0.555556,"avgChangeRate":0.032103},{"month":6,"riseRate":0.5,"avgChangeRate":0.045372},{"month":7,"riseRate":0.375,"avgChangeRate":0.039306},{"month":8,"riseRate":0.375,"avgChangeRate":0.043624},{"month":9,"riseRate":0.5,"avgChangeRate":0.145277},{"month":10,"riseRate":0.25,"avgChangeRate":-0.098431},{"month":11,"riseRate":0.875,"avgChangeRate":0.084928},{"month":12,"riseRate":0.555556,"avgChangeRate":0.043952}],"exchange":"NASDAQ","name":"Kura Oncology, Inc","nameEN":"Kura Oncology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kura Oncology, Inc(KURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kura Oncology, Inc(KURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kura Oncology, Inc,KURA,Kura Oncology, Inc股票,Kura Oncology, Inc股票老虎,Kura Oncology, Inc股票老虎国际,Kura Oncology, Inc行情,Kura Oncology, Inc股票行情,Kura Oncology, Inc股价,Kura Oncology, Inc股市,Kura Oncology, Inc股票价格,Kura Oncology, Inc股票交易,Kura Oncology, Inc股票购买,Kura Oncology, Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kura Oncology, Inc(KURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kura Oncology, Inc(KURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}